About

About PackGene PackGene Biotech, a frontrunner in Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) services, excels in delivering advanced solutions in adeno-associated virus vectors (AAV), mRNA, plasmid DNA, and lentiviral vector (LVV) services. Our expertise extends to early-stage drug discovery, preclinical development, and Cell and Gene Therapy trials, where we offer cost-effective, reliable, and scalable production options. Our π-Alpha 293 AAV High-yield Platform revolutionizes AAV production, boosting yields by up to 10 times compared to conventional methods. This innovation enables us to produce AAV batches up to 1E+17vg, effectively fulfilling the demands of most commercial and clinical projects. In addition to AAV services, PackGene offers customized, scalable plasmid DNA solutions suitable for discovery science, preclinical, and clinical projects, regardless of their size. Our comprehensive approach includes end-to-end design, production, and manufacturing of both new and existing plasmids. With our GMP plasmid Manufacturing Platform, we can scale production from 5L to 200L. We also provide extensive support in process development, analytical development, and cell banking, specifically for AAV, LVV, and plasmid projects, encompassing USP, DSP, and other analytical services. Moreover, PackGene specializes in tailor-made mRNA and LNP solutions, supporting drug and vaccine development through the entire research and GMP production spectrum. At PackGene, our commitment is to drive innovation and progress in biotechnology and healthcare, offering state-of-the-art solutions that align with the dynamic needs of this field.